Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
Guide to Business Plan Writing, 3rd Edition
Overview
D&MD's Guide to Business Plan Writing, 3rd edition helps companies in the life sciences industry create an effective business plan for early and mid-stage stage business ventures. Businesses in the life science industry, which includes biotechnology, agricultural technology, pharmaceutical products, health services and medical devices, face similar hurdles in the development of their businesses. These challenges are often distinct from what is faced in other non-life science based industries.
This Guide outlines the critical components of plan design, provides guidance on effective plan execution, all while placing the process into a life sciences/biotechnology industry context.
This Guide advances the concept of effective business plan writing by offering step-by-step instructions, biotechnology-specific guidance and examples, mini-tutorials on good writing practices, and common mistakes to avoid.
Key Reasons to Buy
* Thoroughly addresses all of the aspects relevant to the creation of a comprehensive business plan for life sciences based company - from the founder's self-assessment of skills, to corporate governance, to share capital structure and beyond.
* This Guide will help you create a well thought out business plan for your specific audience. It enables the reader to create a business plan for the first time or improve and update previous versions of a business plan.
* Includes instructive examples from successful real-world business plans in the areas of financial sourcing, product development, and service provision.
* The Guide goes beyond formulaic, template based approaches to creating business plans. It supplies a detailed planning process requiring input from all stakeholders.
About the Author: Steven Bodovitz, PhD, is a Principal at BioPerspectives, a renowned research and strategy consultancy in San Francisco, California. He is an expert at analyzing markets and developing strategies for the biotechnology industry.
November 2007 Pages 79 Format PDF
Table of Contents
Price: $995.00 / GBP497.50
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.